Success in maintaining ISO 13485 certification in 2024 strengthening Ikonisys’ position in its market and its growth potential – 03/10/2024 at 6:00 p.m.

Paris, France – October 3, 2024 – 6:00 p.m. CEST – Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and precise detection of cancers thanks to a unique and fully automated solution for medical analysis laboratories, announces today the maintenance of its ISO 13485 certification. This reference strengthens the quality management system (QMS, Quality Management System in English) of the Company and reinforces its competitive advantage in markets on a global scale, generating confidence in its operational excellence and its potential for future growth.

The ISO 13485 standard is a globally recognized benchmark for quality management systems in the medical device industry, ensuring that products meet customer and regulatory requirements throughout their lifecycle.